Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience
- PMID: 10903592
- PMCID: PMC1421125
- DOI: 10.1097/00000658-200008000-00003
Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience
Abstract
Objective: To compare the experience and outcome in the management of hilar cholangiocarcinoma at one American and one Japanese medical center.
Summary background data: Controversies surround the issues of extent of resection for hilar cholangiocarcinoma and whether the histopathology of such cancers are similar between patients treated in America and in Japan.
Methods: Records were reviewed of 100 patients treated between 1980 and 1995 at the Lahey Clinic in the United States, and of 155 patients treated between 1977 and 1995 at Nagoya University Hospital in Japan. Selected pathologic slides of resected cancers were exchanged between the two institutions and reviewed for diagnostic concordance.
Results: In the Lahey cohort, there were 25 resections, 53 cases of surgical exploration with biliary bypass or intubation, and 22 cases of percutaneous transhepatic biliary drainage or endoscopic biliary drainage without surgery. In the Nagoya cohort, the respective figures were 122, 10, and 23. The overall 5-year survival rate of all patients treated (surgical and nonsurgical) during the study periods was 7% in the Lahey cohort and 16% in the Nagoya cohort. The overall 10-year survival rates were 0% and 12%, respectively. In patients who underwent resection with negative margins, the 5- and 10-year survival rates were 43% and 0% for the Lahey cohort and 25% and 18% for the Nagoya cohort. The surgical death rate for patients undergoing resection was 4% for Lahey patients and 8% for Nagoya patients. Of the patients who underwent resection, en bloc caudate lobectomy was performed in 8% of the Lahey patients and 89% of the Nagoya patients. Histopathologic examination of resected cancers showed that the Nagoya patients had a higher stage of disease than the Lahey patients.
Conclusions: In both Lahey and Nagoya patients, survival was most favorable when resection of hilar cholangiocarcinoma was accomplished with margin-negative resections. Combined bile duct and liver resection with caudate lobectomy contributed to a higher margin-negative resection rate in the Nagoya cohort.
Figures
Similar articles
-
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.J Hepatobiliary Pancreat Surg. 2000;7(2):155-62. doi: 10.1007/s005340050170. J Hepatobiliary Pancreat Surg. 2000. PMID: 10982608
-
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23. J Hepatobiliary Pancreat Sci. 2010. PMID: 19851704
-
Segmental liver resections for hilar cholangiocarcinoma.Hepatogastroenterology. 1998 Jan-Feb;45(19):7-13. Hepatogastroenterology. 1998. PMID: 9496478
-
Surgery for cholangiocarcinoma.Hepatogastroenterology. 2001 Jan-Feb;48(37):53-5. Hepatogastroenterology. 2001. PMID: 11268998 Review.
-
Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach.J Hepatobiliary Pancreat Surg. 2000;7(2):115-21. doi: 10.1007/s005340050164. J Hepatobiliary Pancreat Surg. 2000. PMID: 10982602 Review.
Cited by
-
Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome.J Gastrointest Surg. 2013 May;17(5):913-24. doi: 10.1007/s11605-013-2144-2. Epub 2013 Jan 15. J Gastrointest Surg. 2013. PMID: 23319395
-
Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer.Langenbecks Arch Surg. 2005 Sep;390(5):421-9. doi: 10.1007/s00423-005-0564-5. Epub 2005 Jun 17. Langenbecks Arch Surg. 2005. PMID: 15965653
-
Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.Langenbecks Arch Surg. 2014 Aug;399(6):693-705. doi: 10.1007/s00423-014-1210-x. Epub 2014 May 20. Langenbecks Arch Surg. 2014. PMID: 24841192 Review.
-
Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution.World J Surg. 2012 May;36(5):1112-1121. doi: 10.1007/s00268-012-1497-0. World J Surg. 2012. PMID: 22374541
-
Comparison of Efficacy and Safety Between Laparoscopic and Open Radical Resection for Hilar Cholangiocarcinoma-A Propensity Score-Matching Analysis.Front Oncol. 2022 Sep 26;12:1004974. doi: 10.3389/fonc.2022.1004974. eCollection 2022. Front Oncol. 2022. PMID: 36226051 Free PMC article.
References
-
- Langer JC, Langer B, Taylor BR, et al. Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach. Surgery 1985; 98: 752–759. - PubMed
-
- Pinson CW, Rossi RL. Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer. World J Surg 1988; 12: 52–59. - PubMed
-
- Pichlmayr R, Ringe B, Lauchart W, et al. Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg 1988; 12: 68–77. - PubMed
-
- Fortner JG, Vitelli CE, Maclean BJ. Proximal extrahepatic bile duct tumors. Analysis of a series of 52 consecutive patients treated over a period of 13 years. Arch Surg 1989; 124: 1275–1279. - PubMed
-
- Cameron JL, Pitt HA, Zinner MJ, et al. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 1990; 159: 91–98. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials